Investigator selection - Dr. Oestreich + Partner GmbH

The success of a clinical trial is based on a number of factors. One very important factor in this success is the establishment of efficient, study-specific criteria for the selection of the investigator. The ethics committees have extremely high standards for the qualification of the investigators. They must provide evidence of professional experience in clinical research and ethical requirements as well as methodological and practical expertise in their specialist field. Likewise, they must have extensive knowledge of quality assurance measures, the special features of the electronic media used and the targeted evaluation of data collection and processing. Ultimately, a substantiated selection of the investigator is crucial for acquiring sponsors.

Click here to find out more about investigator selection at Dr. Oestreich + Partner:

Investigator selection

Informational events and seminars on investigator selection

Dr. Oestreich + Partner GmbH has very successfully been working as a international full-service contract research organization (CRO) in an extremely wide range of indications in clinical research for over twenty years. All members of our highly qualified staff have many years of professional experience in international companies, academic and scientific institutions and hospitals. Our team has extensive, specialist expertise in clinical studies - in both the medical and technical segments. At our training facilities in Cologne, we hold regular training courses, informational events and seminars for clinical research staff. Our competent trainers and instructors also provide further education and informational seminars on the selection of investigators.

Click here for an overview of our range of services in the area of investigator selection:

Investigator selection


EMA Pharmacovigilance
Health care studies
Observational studies
EMA Pharmacovigilance
Medical Biometrics
Approval of Medical Devices
Pharmacovigilance
Clinical Investigators
Clinical Trials
GCP Legislation
GCP - Good Clinical Practice
ICH GCP E6
GCP Guidelines
GCP Compliance
BfArM GCP
Clinical Research Organisation
Contract Research Organisation
PSUR
PSURs
Pharmacoeconomics, Health
Pharmacoeconomic studies
Pharmacoeconomics
Patient Monitoring
Monitoring Clinical Trials
Clinical Monitor
Marketing Authorisation
Medicinal Product Approval
Drug safety
Data management plan
Clinical development
Monitoring investigators
Non-interventional studies (NIS)
Patient recruitment
Phase IV studies
Investigator audit
Investigator qualification
Investigator selection

EMA Pharmacovigilance · Health care studies · Observational studies · EMA Pharmacovigilance · Medical Biometrics · Approval of Medical Devices · Pharmacovigilance · Clinical Investigators · Clinical Trials · GCP Legislation · GCP - Good Clinical Practice · ICH GCP E6 · GCP Guidelines · GCP Compliance · BfArM GCP · Clinical Research Organisation · Contract Research Organisation · PSUR · PSURs · Pharmacoeconomics, Health · Pharmacoeconomic studies · Pharmacoeconomics · Patient Monitoring · Monitoring Clinical Trials · Clinical Monitor · Marketing Authorisation · Medicinal Product Approval · Drug safety · Data management plan · Clinical development · Monitoring investigators · Non-interventional studies (NIS) · Patient recruitment · Phase IV studies · Investigator audit · Investigator qualification · Investigator selection